- Tytuł :
- Optimal Timing of Switching from Platinum-based Chemotherapy to Pembrolizumab for Advanced Urothelial Carcinoma Based on Real-world Data: A Multi-institutional Retrospective Study.
- Autorzy :
- Źródło :
- Anticancer research [Anticancer Res] 2022 Mar; Vol. 42 (3), pp. 1571-1577.
- Typ publikacji :
- Journal Article; Multicenter Study
- MeSH Terms :
-
Drug Substitution */adverse effectsDrug Substitution */mortality
Antibodies, Monoclonal, Humanized/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Carcinoma/*drug therapy
Immune Checkpoint Inhibitors/*administration & dosage
Urinary Bladder Neoplasms/*drug therapy
Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carcinoma/mortality ; Carcinoma/pathology ; Female ; Humans ; Immune Checkpoint Inhibitors/adverse effects ; Japan ; Male ; Middle Aged ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome ; Urinary Bladder Neoplasms/mortality ; Urinary Bladder Neoplasms/pathology -
Czasopismo naukowe